Position in AZN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$18,449,457
-$176,985 QoQ
Shares Held
97,297
+3.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#240
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $214,410,726 across 14 Drug Manufacturers - General names. AZN ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,842 | $81,371,736 | |
| 2 | JNJ |
Johnson & Johnson
|
161,278 | $40,959,773 | |
| 3 | ABBV |
AbbVie Inc.
|
122,381 | $30,795,954 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
97,297 | $18,449,457 | |
| 5 | MRK |
Merck & Co., Inc.
|
96,041 | $12,341,268 | |
| 6 | AMGN |
Amgen Inc
|
23,363 | $8,460,209 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
104,485 | $6,020,425 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
38,585 | $4,874,828 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,449,457 | 97,297 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $18,626,442 | 94,445 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||